首页> 外文期刊>American Journal of Pathology >Prolactin Receptor Expression in the Developing Human Prostate and in Hyperplastic, Dysplastic, and Neoplastic Lesions
【24h】

Prolactin Receptor Expression in the Developing Human Prostate and in Hyperplastic, Dysplastic, and Neoplastic Lesions

机译:催乳素受体在发展中的人类前列腺以及增生,发育不良和赘生性病变中的表达

获取原文
获取原文并翻译 | 示例
           

摘要

In situ hybridization and immunohistochemistry were used to localize and compare the expression of the long form of the human prolactin receptor in fetal, prepubertal, and adult prostate. Results were then compared with hyperplastic, dysplastic, and neoplastic lesions. Both receptor message and protein were predominately localized in epithelial cells of the fetal, neonatal, prepubertal, and normal adult prostate. In hyperplastic lesions the expression of the receptor was unchanged with respect to normal epithelial cells. Irrespective of grade, markedly enhanced expression of the receptor was evident in dysplastic lesions. In lower Gleason grade carcinomas the intensity of receptor signal at the message and protein levels approximated that found in normal prostatic epithelium. However, in foci within higher grade cancers, receptor expression appeared diminished. Results from our study suggest that prolactin action plays a role in the development and maintenance of the human prostate and may also participate in early neoplastic transformation of the gland. Diminution of receptor expression in high grade neoplasms could reflect the emergence of a population of cells that are no longer responsive to the peptide hormone.
机译: 原位杂交和免疫组化方法用于 定位和比较人 催乳素受体的长形式在胎儿,青春期前和成年前列腺中的表达。 然后将结果与增生性,增生性和 肿瘤性病变进行比较。受体信息和蛋白质都主要 定位在胎儿,新生儿,青春期前, 和正常成人前列腺的上皮细胞中。在增生性病变中,相对于正常上皮 细胞,受体的表达 没有变化。无论等级如何,增生性病变中 受体的表达均明显增强。在较低的格里森 等级癌中,消息 上的受体信号强度和蛋白质水平近似于正常前列腺上皮中的水平。但是,在高级别癌症的病灶中,受体 的表达似乎减少了。我们的研究结果表明 催乳素的作用在人类前列腺的发育和维持 中起作用,并且也可能参与了前列腺素的早期肿瘤性转化[sup> 腺体。高档肿瘤中受体表达 的减少可能反映了对肽激素不再反应的细胞 的出现。

著录项

  • 来源
    《American Journal of Pathology》 |1999年第3期|863-870|共8页
  • 作者单位

    From the Department of Pathology,* Tufts University, Schools of Medicine and Veterinary Medicine, Boston, Massachusetts, the Department of Biology, Tufts Unversity, Medford, Massachusetts, the Department of Pathology, Beth Israel Deaconess Medical Center, West Campus, Harvard Medical School, Boston, Massachusetts, and the Department of Urology,§ Stanford Medical Center, Stanford, California;

    From the Department of Pathology,* Tufts University, Schools of Medicine and Veterinary Medicine, Boston, Massachusetts, the Department of Biology, Tufts Unversity, Medford, Massachusetts, the Department of Pathology, Beth Israel Deaconess Medical Center, West Campus, Harvard Medical School, Boston, Massachusetts, and the Department of Urology,§ Stanford Medical Center, Stanford, California;

    From the Department of Pathology,* Tufts University, Schools of Medicine and Veterinary Medicine, Boston, Massachusetts, the Department of Biology, Tufts Unversity, Medford, Massachusetts, the Department of Pathology, Beth Israel Deaconess Medical Center, West Campus, Harvard Medical School, Boston, Massachusetts, and the Department of Urology,§ Stanford Medical Center, Stanford, California;

    From the Department of Pathology,* Tufts University, Schools of Medicine and Veterinary Medicine, Boston, Massachusetts, the Department of Biology, Tufts Unversity, Medford, Massachusetts, the Department of Pathology, Beth Israel Deaconess Medical Center, West Campus, Harvard Medical School, Boston, Massachusetts, and the Department of Urology,§ Stanford Medical Center, Stanford, California;

    From the Department of Pathology,* Tufts University, Schools of Medicine and Veterinary Medicine, Boston, Massachusetts, the Department of Biology, Tufts Unversity, Medford, Massachusetts, the Department of Pathology, Beth Israel Deaconess Medical Center, West Campus, Harvard Medical School, Boston, Massachusetts, and the Department of Urology,§ Stanford Medical Center, Stanford, California;

    From the Department of Pathology,* Tufts University, Schools of Medicine and Veterinary Medicine, Boston, Massachusetts, the Department of Biology, Tufts Unversity, Medford, Massachusetts, the Department of Pathology, Beth Israel Deaconess Medical Center, West Campus, Harvard Medical School, Boston, Massachusetts, and the Department of Urology,§ Stanford Medical Center, Stanford, California;

    From the Department of Pathology,* Tufts University, Schools of Medicine and Veterinary Medicine, Boston, Massachusetts, the Department of Biology, Tufts Unversity, Medford, Massachusetts, the Department of Pathology, Beth Israel Deaconess Medical Center, West Campus, Harvard Medical School, Boston, Massachusetts, and the Department of Urology,§ Stanford Medical Center, Stanford, California;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号